:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FCarawayTx_rgb_large1.png)
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FEyeBio-Logo.png){kind=logo}
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2FICGLOGO.jpg)
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FCarawayTx_rgb_large1.png)
21 November 2023Portfolio NewsDementia Discovery Fund Announces the Acquisition of Caraway Therapeutics by Merck- 21 November 2023Portfolio NewsMerck to Acquire Caraway Therapeutics, Inc.
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FTransposon-logo.png)
14 November 2023Portfolio NewsTransposon Announces Interim Results from a Phase 2 Study of TPN-101 for the Treatment of Progressive Supranuclear Palsy to be Presented at the AD/PD™ 2024 International Conference on Alzheimer's and Parkinson's Diseases
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FEyeBio-Logo.png)
14 November 2023Portfolio NewsEyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FCerevance.jpg)
13 November 2023Portfolio NewsCerevance Doses First Patient in ASCEND Phase 2 Clinical Study of CVN424, a First-in-Class, Non-Dopaminergic Therapy for the Treatment of Parkinson’s Disease
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FImbria_Logo_Colour.png)
12 November 2023Portfolio NewsImbria Reports Positive Topline Results for Investigational New Drug Ninerafaxstat in Patients with Cardiac Ischemia and Chronic Stable Angina- 7 November 2023Portfolio NewsImbria Reports Positive Topline Results for Investigational New Drug Ninerafaxstat in Patients with Non-obstructive Hypertrophic Cardiomyopathy
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FAVDO_2021logo_color.png)
6 November 2023Portfolio NewsAviadoBio Announces FDA IND Clearance and Fast Track Designation for AVB-101 for the Treatment of Frontotemporal Dementia with Progranulin (GRN) Mutations- 1 November 2023Portfolio NewsSitryx announces partner Lilly exercises option to SIT-011 for chronic autoimmune and inflammatory diseases
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FCumulus.png)
18 October 2023Portfolio NewsCumulus Neuroscience to Present Data at CTAD 2023 Annual Meeting
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2Fpulmocide-logo.png)
16 October 2023Portfolio NewsPulmocide Announces New Clinical Data Confirming Low Potential for Drug-Drug Interactions with Inhaled Opelconazole
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FMestag_logo_color.png)
12 October 2023Portfolio NewsMestag Therapeutics announces the appointment of expert advisors Dr. Cassandra Choe-Juliak, Dr. Greg Elson and Samantha Vieira MBA
